Cargando…

Circulating Tumor BRAF Mutation and Personalized Thyroid Cancer Treatment

Detalles Bibliográficos
Autores principales:	Khatami, Fatemeh, Larijani, Bagher, Tavangar, Seyed Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454719/ https://www.ncbi.nlm.nih.gov/pubmed/28345323 http://dx.doi.org/10.22034/APJCP.2017.18.2.293

Ejemplares similares

Personalized treatment options for thyroid cancer: current perspectives
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Oncometabolites as biomarkers in thyroid cancer: a systematic review
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer
por: Khatami, Fatemeh, et al.
Publicado: (2017)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Liquid Biopsy in Thyroid Cancer: New Insight
por: Khatami, Fatemeh, et al.
Publicado: (2018)

A Review of Driver Genetic Alterations in Thyroid Cancers
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
por: Moschovi, Maria, et al.
Publicado: (2015)

Ultrasensitive Detection of BRAF Mutations in Circulating Tumor DNA of Patients With Metastatic Thyroid Cancer
por: Gouda, Mohamed A, et al.
Publicado: (2021)

Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review
por: Khatami, Fatemeh, et al.
Publicado: (2017)

Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives
por: Khatami, Fatemeh, et al.
Publicado: (2018)

BRAF-mutated metastatic colorectal cancer between past and future
por: Cremolini, Chiara, et al.
Publicado: (2015)

Insight on BRAF(V600E) mutated colorectal cancer immune microenvironment
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference
por: Mohammadi, Babak, et al.
Publicado: (2007)

Extranodal Rosai-Dorfman disease involving the meninges in a 79-year-old man
por: Tavangar, Seyed Mohammad, et al.
Publicado: (2006)

Clear Cell Sarcoma: A Case Report and Review of Literature
por: Abdollahi, Alireza, et al.
Publicado: (2018)

Oncometabolites: A new insight for oncology
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
por: Menzies, A M, et al.
Publicado: (2014)

New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017)

Burden of thyroid cancer in North Africa and Middle East 1990–2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2022)

The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream
por: Hasanzad, Mandana, et al.
Publicado: (2019)

Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report
por: Khorsand, Atieh, et al.
Publicado: (2018)

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
por: Dirican, Ebubekir
Publicado: (2020)

A Novel Missense Mutation in BRAF Caused Cardio-Facio-Cutaneous Syndrome
por: Hazan, Filiz, et al.
Publicado: (2013)

The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
por: Nazar, Elham, et al.
Publicado: (2019)

Reply: Comment on ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'
por: Renaud, Stéphane, et al.
Publicado: (2015)

Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
por: Xu, Siyuan, et al.
Publicado: (2020)

Not only Iranian rise in science marred by fraud: Misconduct is a global problem
por: Larijani, Bagher, et al.
Publicado: (2017)

BRAF mutations in thyroid tumors from an ethnically diverse group
por: Schulten, Hans-Juergen, et al.
Publicado: (2012)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

Association of DNA Promoter Methylation and BRAF Mutation in Thyroid Cancer
por: Jasmine, Farzana, et al.
Publicado: (2023)

Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
por: Sigalotti, L, et al.
Publicado: (2011)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
por: Heinzerling, L, et al.
Publicado: (2014)

Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma
por: Kronish, Adam, et al.
Publicado: (2021)

HLA-DR Association in Papillary Thyroid Carcinoma
por: Amoli, Mahsa M., et al.
Publicado: (2010)

Mutational characteristics determined using circulating tumor DNA analysis in triple‐negative breast cancer patients with distant metastasis
por: Rong, Guohua, et al.
Publicado: (2020)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9dan1ob05gqi7mju686nrchckk